Subtyping of breast cancer cell lines reveals insights into cancer-relevant genes

by Manuela Schüngel, Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbHWaterfall plot depicting recurrent non-synonymous mutations in BC cell lines. Mutations were calle

Updated on: March 30,2024

Subtyping of breast cancer cell lines reveals insights into cancer-relevant genes

by Manuela Schüngel, Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbHWaterfall plot depicting recurrent non-synonymous mutations in BC cell lines. Mutations were calle

Updated on:March 30,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on: January 04,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on:January 04,2024

First-of-its-kind tool to check potential inherited risk of pancreatic cancer launches

byUniversity of LiverpoolCredit: Unsplash/CC0 Public DomainFamilies who have been affected by pancreatic cancer can assess their risk of inheriting the disease through a new first-of-its-kind&nb

Updated on: September 30,2024

First-of-its-kind tool to check potential inherited risk of pancreatic cancer launches

byUniversity of LiverpoolCredit: Unsplash/CC0 Public DomainFamilies who have been affected by pancreatic cancer can assess their risk of inheriting the disease through a new first-of-its-kind&nb

Updated on:September 30,2024

Drug resistance is a powerful menace in certain breast and ovarian cancers. Now scientists are figuring out why

by Delthia Ricks , Medical XpressCredit: Unsplash/CC0 Public DomainJust as bacteria, viruses and fungi develop strategies to outsmart antimicrobial medications, cancer cells can become resistant to ch

Updated on: February 18,2024

Drug resistance is a powerful menace in certain breast and ovarian cancers. Now scientists are figuring out why

by Delthia Ricks , Medical XpressCredit: Unsplash/CC0 Public DomainJust as bacteria, viruses and fungi develop strategies to outsmart antimicrobial medications, cancer cells can become resistant to ch

Updated on:February 18,2024

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong

Updated on: January 30,2024

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong

Updated on:January 30,2024

Fatty liver is increasingly the cause of liver cell cancer

by Stefan Zorn, Medizinische Hochschule HannoverCredit: Pixabay/CC0 Public DomainHepatocellular carcinoma (HCC) is one of the most common cancers worldwide. In Germany, there are currently around 9,00

Updated on: January 29,2024

Fatty liver is increasingly the cause of liver cell cancer

by Stefan Zorn, Medizinische Hochschule HannoverCredit: Pixabay/CC0 Public DomainHepatocellular carcinoma (HCC) is one of the most common cancers worldwide. In Germany, there are currently around 9,00

Updated on:January 29,2024

Pancreatic tumors may require a one-two-three punch

by University of Rochester Medical CenterThe colors in this cell culture show action taken by pancreas cancer when it recruits harmful cells to the tumor that suppress the body’s natural immune s

Updated on: March 09,2024

Pancreatic tumors may require a one-two-three punch

by University of Rochester Medical CenterThe colors in this cell culture show action taken by pancreas cancer when it recruits harmful cells to the tumor that suppress the body’s natural immune s

Updated on:March 09,2024

Researchers identify one driver of melanoma spread

by Amy Mone,Johns Hopkins UniversityCredit: AI-generated imageUsing a small noncoding RNA, microRNA 211, and tools that track the stability and decay of the protein-coding and noncoding RNAs in

Updated on: June 22,2024

Researchers identify one driver of melanoma spread

by Amy Mone,Johns Hopkins UniversityCredit: AI-generated imageUsing a small noncoding RNA, microRNA 211, and tools that track the stability and decay of the protein-coding and noncoding RNAs in

Updated on:June 22,2024

Researchers exploit DNA amplification in cancer to halt chemoresistance

by Stony Brook UniversityGábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on thePNASpaper. Credit: John Gr

Updated on: June 08,2024

Researchers exploit DNA amplification in cancer to halt chemoresistance

by Stony Brook UniversityGábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on thePNASpaper. Credit: John Gr

Updated on:June 08,2024

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on: April 07,2024

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on:April 07,2024

An accurate integrated imaging and projection system for oral cancer diagnosis

by SPIEImaging workflow of the ABGS. Step 1: widefield images are acquired using the camera and projector. Step 2: a cancer risk map is generated and projected onto the oral cavity. Step 3: multi

Updated on: February 18,2024

An accurate integrated imaging and projection system for oral cancer diagnosis

by SPIEImaging workflow of the ABGS. Step 1: widefield images are acquired using the camera and projector. Step 2: a cancer risk map is generated and projected onto the oral cavity. Step 3: multi

Updated on:February 18,2024

New blood test developed to diagnose ovarian cancer

by Brigham and Women's HospitalIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epitheliu

Updated on: April 14,2024

New blood test developed to diagnose ovarian cancer

by Brigham and Women's HospitalIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epitheliu

Updated on:April 14,2024